Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust, Sanger, Perlegen, and Affy to Genotype 15K Samples in Search of Complex Disease Genes

NEW YORK, Oct. 5 (GenomeWeb News) - The Wellcome Trust Case Control Consortium, the Wellcome Trust Sanger Institute, Perlegen Sciences, and Affymetrix will jointly search for genes associated with 10 complex diseases, the partners said today.


The consortium plans to study 11,000 samples to find genes associated with coronary heart disease, hypertension, types 1 and 2 diabetes, bipolar disorder, Crohn's disease, rheumatoid arthritis, and tuberculosis. The Wellcome Trust Sanger Institute will analyze an additional 4,000 samples to find the genetic origins of diseases such as types 1 and 2 diabetes, obesity, and malaria.


Perlegen will genotype the 15,000 individuals, producing more than 10 billion genotypes, using Affymetrix's microarray technology, including the Human Mapping 500K array set.


The WTCCC is a team of 24 human geneticists at a number of UKinstitutions, including the Wellcome Trust Sanger Institute, LeicesterUniversity, CambridgeUniversityand Oxford Unviersity.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.